메뉴 건너뛰기




Volumn 60, Issue 1, 2005, Pages 17-23

Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs

Author keywords

Beta blocker; Chronopharmacotherapy; Controlled release; Dog study; Immediate release; In vivo study; LC MS MS; Metoprolol; Pharmacokinetics; Pulsatile drug delivery; Pulsatile release; Sustained release

Indexed keywords

METOPROLOL; METOPROLOL TARTRATE;

EID: 17444385204     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.11.010     Document Type: Article
Times cited : (36)

References (31)
  • 1
    • 0037310818 scopus 로고    scopus 로고
    • Pharmacokinetic considerations of formulation: Extended-release metoprolol succinate in the treatment of heart failure
    • J. Wikstrand, B. Andersson, M.J. Kendall, H. Stanbrook, and M. Klibaner Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure J. Cardiovasc. Pharmacol. 41 2003 151 157
    • (2003) J. Cardiovasc. Pharmacol. , vol.41 , pp. 151-157
    • Wikstrand, J.1    Andersson, B.2    Kendall, M.J.3    Stanbrook, H.4    Klibaner, M.5
  • 2
    • 0025076616 scopus 로고
    • Long-acting propranolol in the prophylaxis of migraine: A comparative study of two doses
    • J.D. Carroll, M. Reidy, P.A. Savundra, N. Cleave, and J. McAinsh Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses Cephalalgia 10 1990 101 105
    • (1990) Cephalalgia , vol.10 , pp. 101-105
    • Carroll, J.D.1    Reidy, M.2    Savundra, P.A.3    Cleave, N.4    McAinsh, J.5
  • 3
    • 0035808267 scopus 로고    scopus 로고
    • Novel pH sensitive citrate cross-linked chitosan film for drug controlled release
    • X.Z. Shu, K.J. Zhu, and W. Song Novel pH sensitive citrate cross-linked chitosan film for drug controlled release Int. J. Pharm. 212 2001 19 28
    • (2001) Int. J. Pharm. , vol.212 , pp. 19-28
    • Shu, X.Z.1    Zhu, K.J.2    Song, W.3
  • 4
    • 0028832474 scopus 로고
    • Approaches and opportunities in colon-specific drug delivery
    • A. Rubinstein Approaches and opportunities in colon-specific drug delivery Crit. Rev. Ther. Drug Carrier Syst. 12 1995 101 149
    • (1995) Crit. Rev. Ther. Drug Carrier Syst. , vol.12 , pp. 101-149
    • Rubinstein, A.1
  • 6
    • 0017383466 scopus 로고
    • Infuence of food and diet on gastrointestinal drug absorption: A review
    • P.G. Welling Infuence of food and diet on gastrointestinal drug absorption: a review J. Pharmacokinet. Biopharm. 5 1977 291 334
    • (1977) J. Pharmacokinet. Biopharm. , vol.5 , pp. 291-334
    • Welling, P.G.1
  • 7
    • 0037243824 scopus 로고    scopus 로고
    • Effects of food on the pharmacokinetics of levodopa in a dual-release formulation
    • C. Crevoisier, P. Zerr, F. Calvi-Gries, and T. Nilsen Effects of food on the pharmacokinetics of levodopa in a dual-release formulation Eur. J. Pharm. Biopharm. 55 2003 71 76
    • (2003) Eur. J. Pharm. Biopharm. , vol.55 , pp. 71-76
    • Crevoisier, C.1    Zerr, P.2    Calvi-Gries, F.3    Nilsen, T.4
  • 8
    • 0027212070 scopus 로고
    • Nitrate tolerance - Mechanisms and prevention
    • H. Kertland Nitrate tolerance - mechanisms and prevention Conn. Med. 57 1993 232 234
    • (1993) Conn. Med. , vol.57 , pp. 232-234
    • Kertland, H.1
  • 9
    • 85030795471 scopus 로고    scopus 로고
    • Port-Systems. Port Capsule. US Patent: 5,387,421. USA, 1995.
    • Port-Systems. Port Capsule. US Patent: 5,387,421. USA, 1995.
  • 10
    • 0242334031 scopus 로고    scopus 로고
    • Drug therapy in the elderly
    • R.E. Noble Drug therapy in the elderly Metab.-Clin. Exp. 52 2003 27 30
    • (2003) Metab.-Clin. Exp. , vol.52 , pp. 27-30
    • Noble, R.E.1
  • 11
    • 0037275143 scopus 로고    scopus 로고
    • The influence of sex on pharmacokinetics
    • J.B. Schwartz The influence of sex on pharmacokinetics Clin. Pharmacokinet. 42 2003 107 121
    • (2003) Clin. Pharmacokinet. , vol.42 , pp. 107-121
    • Schwartz, J.B.1
  • 12
    • 0031750861 scopus 로고    scopus 로고
    • Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
    • E. Galia, E. Nicolaides, D. Horter, R. Lobenberg, C. Reppas, and J.B. Dressman Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharm. Res. 15 1998 698 705
    • (1998) Pharm. Res. , vol.15 , pp. 698-705
    • Galia, E.1    Nicolaides, E.2    Horter, D.3    Lobenberg, R.4    Reppas, C.5    Dressman, J.B.6
  • 13
    • 85030797836 scopus 로고
    • Effect of the test parameters on dissolution rate
    • Mack Publishing Company Easton, PA
    • H.M. Abdou Effect of the test parameters on dissolution rate Dissolution, Bioavailability and Bioequivalence 1989 Mack Publishing Company Easton, PA 145 171
    • (1989) Dissolution, Bioavailability and Bioequivalence , pp. 145-171
    • Abdou, H.M.1
  • 14
    • 0028906632 scopus 로고
    • Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation
    • N. Katori, N. Aoyagi, and T. Terao Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation Pharm. Res. 12 1995 237 243
    • (1995) Pharm. Res. , vol.12 , pp. 237-243
    • Katori, N.1    Aoyagi, N.2    Terao, T.3
  • 15
    • 0025157303 scopus 로고
    • Effect of formulation variables on the preparation and in vitro-in vivo evaluation of cimetidine release from ethylcellulose micropellets
    • S.C. Chattaraj, and S.K. Das Effect of formulation variables on the preparation and in vitro-in vivo evaluation of cimetidine release from ethylcellulose micropellets Drug Dev. Ind. Pharm. 16 1990 283 293
    • (1990) Drug Dev. Ind. Pharm. , vol.16 , pp. 283-293
    • Chattaraj, S.C.1    Das, S.K.2
  • 16
    • 0031771036 scopus 로고    scopus 로고
    • Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets
    • N.D. Eddington, M. Ashraf, L.L. Augsburger, J.L. Leslie, M.J. Fossler, L.J. Lesko, V.P. Shah, and G.S. Rekhi Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets Pharm. Dev. Technol. 3 1998 535 547
    • (1998) Pharm. Dev. Technol. , vol.3 , pp. 535-547
    • Eddington, N.D.1    Ashraf, M.2    Augsburger, L.L.3    Leslie, J.L.4    Fossler, M.J.5    Lesko, L.J.6    Shah, V.P.7    Rekhi, G.S.8
  • 17
    • 0025264642 scopus 로고
    • Pharmacokinetic and pharmacodynamic comparison of metoprolol Cr Zok once daily with conventional tablets once daily and in divided doses
    • P. Lucker, G. Moore, I. Wieselgren, B. Olofsson, and R. Bergstrand Pharmacokinetic and pharmacodynamic comparison of metoprolol Cr Zok once daily with conventional tablets once daily and in divided doses J. Clin. Pharmacol. 30 1990 S17 S27
    • (1990) J. Clin. Pharmacol. , vol.30
    • Lucker, P.1    Moore, G.2    Wieselgren, I.3    Olofsson, B.4    Bergstrand, R.5
  • 18
    • 0036223864 scopus 로고    scopus 로고
    • Time-patterned drug administration: Insights from a modeling approach
    • A. Goldbeter, and D. Claude Time-patterned drug administration: insights from a modeling approach Chronobiol. Int. 19 2002 157 175
    • (2002) Chronobiol. Int. , vol.19 , pp. 157-175
    • Goldbeter, A.1    Claude, D.2
  • 19
    • 0025854129 scopus 로고
    • Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs. Propranolol, organic nitrates, nifedipine
    • B. Lemmer, B. Scheidel, and S. Behne Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs. Propranolol, organic nitrates, nifedipine Ann. NY Acad. Sci. 1991 618
    • (1991) Ann. NY Acad. Sci. , pp. 618
    • Lemmer, B.1    Scheidel, B.2    Behne, S.3
  • 20
    • 0029740021 scopus 로고    scopus 로고
    • Chronopharmacologic considerations when treating the patient with hypertension: A review
    • R.J. Straka, and S.R. Benson Chronopharmacologic considerations when treating the patient with hypertension: a review J. Clin. Pharmacol. 36 1996 771 782
    • (1996) J. Clin. Pharmacol. , vol.36 , pp. 771-782
    • Straka, R.J.1    Benson, S.R.2
  • 22
    • 0032819759 scopus 로고    scopus 로고
    • Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations
    • M. Halsas, J. Hietala, P. Veski, H. Jurjenson, and M. Marvola Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations Int. J. Pharm. 189 1999 179 185
    • (1999) Int. J. Pharm. , vol.189 , pp. 179-185
    • Halsas, M.1    Hietala, J.2    Veski, P.3    Jurjenson, H.4    Marvola, M.5
  • 23
    • 0037277973 scopus 로고    scopus 로고
    • Use of chronobiology findings in therapy of cardiovascular diseases
    • M. Kozak Use of chronobiology findings in therapy of cardiovascular diseases Vnitrni Lekarstvi 49 2003 308 313
    • (2003) Vnitrni Lekarstvi , vol.49 , pp. 308-313
    • Kozak, M.1
  • 24
    • 0031896052 scopus 로고    scopus 로고
    • Chronopharmacological aspects for the prevention of acute coronary syndromes
    • B. Lemmer Chronopharmacological aspects for the prevention of acute coronary syndromes Eur. Heart J. 19 1998 C50 C58
    • (1998) Eur. Heart J. , vol.19
    • Lemmer, B.1
  • 25
    • 0029583114 scopus 로고
    • Celiprolol double-peak occurrence and gastric motility: Nonlinear mixed effects modeling of bioavailability data obtained in dogs
    • E. Lipka, I.D. Lee, P. Langguth, H. Spahn-Langguth, E. Mutschler, and G.L. Amidon Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs J. Pharmacokinet. Biopharm. 23 1995 267 286
    • (1995) J. Pharmacokinet. Biopharm. , vol.23 , pp. 267-286
    • Lipka, E.1    Lee, I.D.2    Langguth, P.3    Spahn-Langguth, H.4    Mutschler, E.5    Amidon, G.L.6
  • 26
    • 0023425558 scopus 로고
    • The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; An explanation for the double peak phenomenon
    • R.L. Oberle, and G.L. Amidon The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon J. Pharmacokinet. Biopharm. 15 1987 529 544
    • (1987) J. Pharmacokinet. Biopharm. , vol.15 , pp. 529-544
    • Oberle, R.L.1    Amidon, G.L.2
  • 28
    • 0037177460 scopus 로고    scopus 로고
    • Comparison of the mechanical destructive force in the small intestine of dog and human
    • M. Kamba, Y. Seta, A. Kusai, and K. Nishimura Comparison of the mechanical destructive force in the small intestine of dog and human Int. J. Pharm. 237 2002 139 149
    • (2002) Int. J. Pharm. , vol.237 , pp. 139-149
    • Kamba, M.1    Seta, Y.2    Kusai, A.3    Nishimura, K.4
  • 29
    • 0027674638 scopus 로고
    • Chronopharmacology and DDS (drug delivery system)
    • N. Ogawa, and S. Ohdo Chronopharmacology and DDS (drug delivery system) Nippon Rinsho 51 1993 2778 2787
    • (1993) Nippon Rinsho , vol.51 , pp. 2778-2787
    • Ogawa, N.1    Ohdo, S.2
  • 30
    • 0031946803 scopus 로고    scopus 로고
    • Pulsatile drug release from an insoluble capsule body controlled by an erodible plug
    • I. Krogel, and R. Bodmeier Pulsatile drug release from an insoluble capsule body controlled by an erodible plug Pharm. Res. 15 1998 474 481
    • (1998) Pharm. Res. , vol.15 , pp. 474-481
    • Krogel, I.1    Bodmeier, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.